- CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – NEITHER THROMBOLYSIS NOR THROMBECTOMY
- CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – THROMBOLYSIS OR THROMBECTOMY
- CLINICAL TRIAL RESULTS – PREVENTION
- CLINICAL TRIAL RESULTS – REHABILITATION & RECOVERY
- THROMBOLYSIS – EXCLUDING CLINICAL TRIAL RESULTS
- HYPERACUTE MANAGEMENT – EXCLUDING CLINICAL TRIAL RESULTS
- NEUROINTERVENTION – EXCLUDING CLINICAL TRIAL RESULTS
- REHABILITATION – EXCLUDING CLINICAL TRIAL RESULTS
- RISK FACTORS AND PREVENTION
- SECONDARY PREVENTION – EXCLUDING CLINICAL TRIAL RESULTS
- IMAGING – HYPERACUTE
- IMAGING – NON ACUTE INCLUDING NEUROSONOLOGY
- SERVICE ORGANISATION/QUALITY IMPROVEMENT
- CLINICAL PRACTICE, MANAGEMENT AND CARE
- DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY
- PROGNOSIS AND OUTCOME AFTER STROKE
- STROKE COMPLICATIONS
- PATHOPHYSIOLOGY OF STROKE
- BRAIN REORGANISATION AND RECOVERY
- LARGE ARTERY ATHEROSCLEROSIS – INCLUDING INTRACRANIAL STENOSIS
- RARE CAUSES, STROKE IN THE YOUNG
- INTRACEREBRAL HAEMORRHAGE
- ATRIAL FIBRILLATION, CARDIOEMBOLISM & HEART-BRAIN INTERACTIONS
- COGNITION AND VASCULAR COGNITIVE IMPAIRMENT
- SMALL VESSEL DISEASE
- SAH, ANEURYSMS AND VASCULAR MALFORMATIONS
- TIA
- SEX, GENDER AND STROKE PREVENTION, TREATMENT, AND RECOVERY
- YOUNG STROKE PHYSICIANS AND RESEARCHERS: RESEARCH DESIGN WORKSHOP FOR STUDIES IN DEVELOPMENT *
- EXPERIMENTAL/TRANSLATIONAL MEDICINE
- GENETICS, ‘OMICS AND BIOMARKERS
- SYSTEMATIC REVIEW AND META-ANALYSIS
- CASE REPORTS
- CEREBROVASCULAR MANIFESTATIONS OF COVID-19 AND OTHER INFECTIONS
- TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE